Oculis completes patient enrollment in Licaminlimab trial for dry eye disease, targeting a specific genetic variant linked to ...
Oculis announces completion of enrollment in PREDICT-1 trial for Licaminlimab, targeting precision treatment for dry eye ...
Red Cat Holdings proposes to acquire Steyr Motors for EUR 39.00 per share, enhancing defense capabilities and growth ...
Evaxion A/S announced new three-year clinical outcome data from its phase 2 trial evaluating the personalized cancer vaccine EVX-01 in patients with advanced melanoma. The findings show that all ...
Van Drew says ICE confirmed suspect status: Congressman Jefferson Van Drew said U.S. Immigration and Customs Enforcement and ...
Beyer criticizes East Potomac Park project: Rep. Don Beyer said President Trump’s announcement about East Potomac Park ...
Eikon Therapeutics presents updates on its oncology pipeline at the 2026 ESMO Congress, highlighting several clinical studies ...
Roundtable on wildfire technology: Rep. Young Kim said she convened federal, state and local firefighting agencies, policy ...
Speaker Johnson interview highlights: Speaker Mike Johnson spoke with CBS News’ Robert Costa during a visit to Louisiana’s ...
Senator John Fetterman just disclosed $424.1K of fundraising in a Q3 FEC disclosure filed on October 15th, 2026. This is the ...
Representative Paul A. Gosar just disclosed $183.2K of fundraising in a Q3 FEC disclosure filed on October 15th, 2026. This ...
Senator James E. Risch just disclosed $35.0K of fundraising in a Q3 FEC disclosure filed on October 15th, 2026. This is the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results